FDA Investigator Kish Bolden
Kish Bolden has inspections in 1 countries as of 01 Nov 2023. Kish Bolden has collaborated with a combined 1133 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
44
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Anastasia M Shields,
Angel F Colon,
Anita R Michael,
Ann Marie Karnick,
Anne E Johnson,
Anne Efenton Johnson,
Barbara A Gullick,
Brian S Keefer,
Cara M Minelli,
Craig D Zagata,
Daniel T Lee,
Daniel W Johnson,
David L Pearce,
Dawn D Aiello,
Denise M Visco, Investigator,
Diane M Gubernot,
Edwin L Hobbs,
Emily A Walters,
Erika M Wilkerson,
Gayle S Lawson,
Hala L Selby,
James M Mason,
James P Mcevoy,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Judy Ellen Ciaraldi,
Julianne C Mccullough,
Kimberly A Dux,
Kip J Hanks,
Kristina J Donohue,
Laurie A Haxel,
LCDR Margaret E Digennaro,
Linda M Hoover,
Linda S Mattingly,
Lisa Harlan,
Lisa L Caulder,
Loretta Nemchik,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Matthew R Noonan,
Megan F Mclaughlin,
Megan M Lauff,
Michael J Nerz,
Michele M Falchek,
Mike M Rashti,
Miriam Montes,
Nancy L Rose,
Nerizza B Guerin,
Nikisha M Bolden,
Rita F Larocca Mahoney,
Robert B Shibuya, MD,
Ronald A Stokes,
Sarah Forney,
Sean D Duke,
Stephanie Mangigian, MS/OSH, RN,
Steven D Banks,
Suzanne M Healy,
Tania E Vizcaino,
Thomas E Friel,
Timothy J Schmidt,
Todd J Maushart,
Travis R Hunt
Kish Bolden's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2023 | FDA 483 | ABO Plasma Glassboro LLC - Form 483, 2023-03-14 |
June, 2022 | FDA 483 | Main Line Fertility Center - Form 483, 2022-06-30 |
January, 2020 | FDA 483 | Dr. Louis R. Manara - Form 483, 2020-01-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more